Parkman Healthcare Partners LLC Bridge Bio Pharma, Inc. Transaction History

Parkman Healthcare Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $17,630 - $32,215	734 Added 0.73%	100,734 $4.07 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $1.69 Million - $3.5 Million	100,000 New	100,000 $2.64 Million
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $659,789 - $3.1 Million	-57,978 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $334,398 - $460,040	-7,196 Reduced 11.04%	57,978 $3.53 Million
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $608,450 - $793,607	-10,969 Reduced 14.41%	65,174 $4.02 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $35,117 - $65,065	915 Added 1.22%	76,143 $5.42 Million
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $353 - $548	13 Added 0.02%	75,228 $2.82 Million
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $1.21 Million - $2.73 Million	75,215 New	75,215 $2.18 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.